Next generation sequencing (NGS) is the method of choice for simultaneous genomic profiling of multiple biomarkers. Researchers use rhAmpSeqTM and xGenTM targeted sequencing systems to amplify highly multiplexed targets. This combination offers flexible, high-quality solutions for targeted sequencing, accelerating human disease research.
Download this application note from Integrated DNA Technologies to learn how researchers use combined NGS approaches to identify and confirm biomarkers in cancer samples.
For research use only. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.